Completed PHASE3 INTERVENTIONAL 2-arm NCT00451646

Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

A Double-blind, Randomised Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

Sponsor: Fresenius Kabi

Conditions Parenteral Nutrition

Interventions SMOF lipid and Intralipid

Updated 6 times since 2017 Last updated: Aug 26, 2010 Started: Oct 31, 2007 Primary completion: Oct 31, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00451646, this PHASE3 trial focuses on Parenteral Nutrition and remains completed. Sponsored by Fresenius Kabi, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fresenius Kabi

Data source: Fresenius Kabi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Clichy, France , Copenhagen, Denmark , Krakow, Poland , Lyon, France , Manchester, United Kingdom , Melbourne, Australia , Nijmegen, Netherlands , Nottingham, United Kingdom , Petah Tikva, Israel and 2 more locations